Overview of the treatment of infant central nervous system tumors: Medulloblastoma as a modell

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 5, 2001, Pages 268-271

  Heideman, Richard L ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; METHOTREXATE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; HUMAN; MEDULLOBLASTOMA; NOTE; PRIORITY JOURNAL; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUSULFAN; CARBOPLATIN; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; EPENDYMOMA; ETOPOSIDE; FOLLOW-UP STUDIES; HUMANS; INFANT; MEDULLOBLASTOMA; MULTICENTER STUDIES; NEUROECTODERMAL TUMORS, PRIMITIVE; PILOT PROJECTS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RISK; SURVIVAL RATE; THIOTEPA; TOPOTECAN; TREATMENT OUTCOME; VINCRISTINE;

EID: 0034923619     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200106000-00006     Document Type: Editorial

References (17)

1. Horowitz ME, Kun LE, Mulhern RK, et al. Feasibility and efficacy of preirradiation chemotherapy for pediatric brain tumors. Neurosurgery 1988; 22 (4): 687-90.
2. Kretschmar CS, Tarbell NJ, Kupsky W, et al. Pre-irradiation chemotherapy for infants and children with medulloblastoma: a preliminary report. J Neurosurg 1989; 71: 820-5.
3. Ater JL, van Eys J, Woo SY, et al. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children. J Neurooncol 1997; 32: 243-52.
4. Duffner PK, Horowitz ME, Krischer JP, et al. The treatment of malignant brain tumors in infants and very young children: An update of the Pediatric Oncology Group experience. Neurooncology 1999; 1: 152-61.
5. Strother D, Kepner J, Aroninn P, et al. Dose-intensive chemotherapy prolongs event-free survival of infants and young children with ependymoma: Results of Pediatric Oncology Group (POG) study 9233 [abstract]. Proc Am Soc Clin Oncol 2000; 19; 2303.
6. Geyer JR, Zeltzer PM, Boyett JM, et al. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the Childrens Cancer Group. J Clin Oncol 1994; 12 (8): 1607-15.
7. Heideman R, Phillips P, Friedman H, et al. A cooperative study of carboplatin based primary chemotherapy for infants and young children with CNS tumors. Proc Am Soc Clin Oncol 1998; 17: 2051.
8. Mason WP, Grovas A, Halpern S, et al. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol 1998; 16 (1): 210-21.
9. Lashford LS, Campbell RHA, Grattamaneni RH, et al. An intensive multiagent chemotherapy regimen for brain tumors occurring in very young children. Arch Dis Child 1996; 74; 219-23.
10. Walter AW, Mulhern RK, Gajjar A, et al. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol 1999; 17 (12): 3720-8.
11. Packer RJ, Goldwein J, Nicholson HS, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group study. J Clin Oncol 1999; 17 (7): 2127-36.
12. Goldwein JW, Radcliffe J, Johnson J, et al. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int J Radiat Oncol Biol Phys 1996; 34 (4): 899-904.
13. Ater JL, van Eys J, Woo SY, et al. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children. J Neurooncol 1997; 32: 243-52.
14. th International Symposium on Pediatric Neuro-oncology; May 6-8, 1998; Rome.
15. Warmuth-Metz M, Kuhl J. Incidence of leukoencephalopathy after radiation and after chemotherapy with intravenous and intraventricular methotrexate (poster). Ninth International Symposium on Pediatric Neurooncology; June 11-14, 2000; San Francisco, CA.
16. Dupuis-Girod S, Hartmann O, Benhamou E, et al. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma? J Neurooncol 1996; 27: 897-98.
17. Blaney SM, Balis FM, Poplack DG. Pharmacologic approaches to the treatment of meningeal malignancy. Oncology 1991; 5: 107-16.